Division of Endocrine Surgery, University of Michigan, 2920F Taubman Center, 1500 E. Medical Center Drive, Ann Arbor, MI 48109, USA.
World J Surg. 2010 Jun;34(6):1380-5. doi: 10.1007/s00268-010-0532-2.
Complete surgical resection is the mainstay of treatment for patients with adrenocortical cancer (ACC). Use of laparoscopy has been questioned in patients with ACC. This study compares the outcomes of patients undergoing laparoscopic versus open resection (OR) for ACC.
A retrospective review (2003-2008) of patients with ACC was performed. Data were collected for demographics, operative and pathologic data, adjuvant therapy, and outcome. Chi-square analysis was performed.
Eighty-eight patients (66% women; median age, 47 (range, 18-81) years) were identified. Seventeen patients underwent laparoscopic adrenalectomy (LA). Median tumor size of those who underwent LA was 7.0 (range, 4-14) cm versus 12.3 (range, 5-27) cm for OR. Recurrent disease in the laparoscopic group occurred in 63% versus 65% in the open group. Mean time to first recurrence for those who underwent LA was 9.6 months (+/-14) versus 19.2 months (+/-37.5) in the open group (p < 0.005). Fifty percent of patients who underwent LA had positive margins or notation of intraoperative tumor spill versus 18% of those who underwent OR (p = 0.01). Local recurrence occurred in 25% of the laparoscopic group versus 20% in the open group (p = 0.23). Mean follow-up was 36.5 months (+/-43.6).
ACC continues to be a deadly disease, and little to no progress has been made from a treatment standpoint in the past 20 years. Careful and complete surgical resection is of the utmost importance. Although feasible in many cases and tempting, laparoscopic resection should not be attempted in patients with tumors suspicious for or known to be adrenocortical carcinoma.
完整的手术切除是治疗肾上腺皮质癌 (ACC) 患者的主要手段。腹腔镜的使用在 ACC 患者中受到质疑。本研究比较了接受腹腔镜与开放切除术 (OR) 的 ACC 患者的结果。
对 2003-2008 年接受 ACC 治疗的患者进行回顾性研究。收集人口统计学、手术和病理数据、辅助治疗和结果数据。进行卡方检验。
共确定了 88 例患者(66%为女性;中位年龄为 47 岁(范围,18-81 岁))。17 例患者接受了腹腔镜肾上腺切除术 (LA)。LA 组的肿瘤中位大小为 7.0cm(范围,4-14cm),而 OR 组为 12.3cm(范围,5-27cm)。LA 组的复发病例发生率为 63%,OR 组为 65%。LA 组的首次复发时间平均为 9.6 个月(+/-14),OR 组为 19.2 个月(+/-37.5)(p<0.005)。LA 组有 50%的患者存在肿瘤边缘阳性或术中肿瘤溢出,而 OR 组为 18%(p=0.01)。LA 组局部复发率为 25%,OR 组为 20%(p=0.23)。平均随访时间为 36.5 个月(+/-43.6)。
ACC 仍然是一种致命的疾病,在过去 20 年中,从治疗角度来看,几乎没有取得任何进展。仔细和完整的手术切除是至关重要的。尽管在许多情况下是可行的,并且具有吸引力,但腹腔镜切除不应在怀疑或已知为肾上腺皮质癌的患者中进行。